• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients.

作者信息

Mazumder A, Kaufman J, Niesvizky R, Lonial S, Vesole D, Jagannath S

出版信息

Leukemia. 2008 Jun;22(6):1280-1; author reply 1281-2. doi: 10.1038/sj.leu.2405035. Epub 2007 Nov 22.

DOI:10.1038/sj.leu.2405035
PMID:18033320
Abstract
摘要

相似文献

1
Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients.来那度胺治疗对既往未经治疗的多发性骨髓瘤患者外周血干细胞动员的影响。
Leukemia. 2008 Jun;22(6):1280-1; author reply 1281-2. doi: 10.1038/sj.leu.2405035. Epub 2007 Nov 22.
2
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.在骨髓瘤患者中，来那度胺诱导治疗后干细胞动员受损。
Leukemia. 2008 Jun;22(6):1282-4. doi: 10.1038/sj.leu.2405100. Epub 2008 Jan 24.
3
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.多发性骨髓瘤患者在先前使用来那度胺后，非格司亭诱导的干细胞动员受损。
Biol Blood Marrow Transplant. 2009 Jun;15(6):718-23. doi: 10.1016/j.bbmt.2009.02.011. Epub 2009 Apr 8.
4
Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.新型诱导疗法治疗多发性骨髓瘤患者的外周血造血干细胞动员：中剂量与低剂量环磷酰胺和粒细胞集落刺激因子。
Biol Blood Marrow Transplant. 2012 Jul;18(7):1128-35. doi: 10.1016/j.bbmt.2012.01.005. Epub 2012 Jan 14.
5
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.环磷酰胺用于干细胞动员可克服来那度胺治疗对多发性骨髓瘤干细胞采集的抑制作用。
Biol Blood Marrow Transplant. 2008 Jul;14(7):795-8. doi: 10.1016/j.bbmt.2008.04.008.
6
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
7
Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen.多发性骨髓瘤患者的干细胞采集：诱导治疗和动员方案的影响。
Bone Marrow Transplant. 2011 Jan;46(1):59-63. doi: 10.1038/bmt.2010.63. Epub 2010 May 3.
8
Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma.
Acta Haematol. 2003;109(4):184-8. doi: 10.1159/000070967.
9
[Effect of bortezomib on the efficiency of hematopoietic stem cell mobilization in patients with multiple myeloma].硼替佐米对多发性骨髓瘤患者造血干细胞动员效率的影响
Ter Arkh. 2012;84(7):35-41.
10
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.来那度胺治疗对新诊断骨髓瘤患者外周血干细胞移植后干细胞动员和植入的影响。
Leukemia. 2007 Sep;21(9):2035-42. doi: 10.1038/sj.leu.2404801. Epub 2007 Jun 21.

引用本文的文献

1
Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma.多发性骨髓瘤自体造血细胞移植中普乐沙福节省动员方案的分析
Ann Hematol. 2024 Dec;103(12):6027-6030. doi: 10.1007/s00277-024-05935-1. Epub 2024 Aug 13.
2
Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.硼替佐米、环磷酰胺和地塞米松对新诊断的POEMS综合征患者的疗效。
Ther Adv Neurol Disord. 2024 Jan 27;17:17562864231219151. doi: 10.1177/17562864231219151. eCollection 2024.
3
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.
环磷酰胺联合粒细胞集落刺激因子（G-CSF）长时间输注作为动员方案可能会提高初诊多发性骨髓瘤患者的动员效率：单中心经验。
Ann Med. 2023;55(2):2289603. doi: 10.1080/07853890.2023.2289603. Epub 2023 Dec 17.
4
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.一项关于德国范围内多发性骨髓瘤动员不佳患者在自体干细胞移植前造血干细胞动员与采集的系统性研究。
Transfus Med Hemother. 2023 Oct 16;50(6):475-490. doi: 10.1159/000531935. eCollection 2023 Dec.
5
A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.一项关于新型药物治疗多发性骨髓瘤患者用环磷酰胺联合粒细胞集落刺激因子和按需使用plerixafor进行造血干细胞动员的前瞻性、多中心研究。
Haematologica. 2024 May 1;109(5):1525-1534. doi: 10.3324/haematol.2023.284023.
6
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.临床参数和诱导方案对多发性骨髓瘤患者外周血干细胞动员及采集的影响
Transfus Med Hemother. 2023 Jun 5;50(5):382-395. doi: 10.1159/000530056. eCollection 2023 Oct.
7
Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings.多发性骨髓瘤自体造血干细胞移植（HSCT）的长期结果：尽管新的前景出现，但对于资源有限的环境而言，它仍然只是一线希望。
Cureus. 2023 Mar 24;15(3):e36642. doi: 10.7759/cureus.36642. eCollection 2023 Mar.
8
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122).来那度胺联合粒细胞集落刺激因子动员多发性骨髓瘤患者造血干细胞：前瞻性多中心观察研究（KMM122）。
Cancer Med. 2023 Apr;12(8):9186-9193. doi: 10.1002/cam4.5657. Epub 2023 Mar 23.
9
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.在新冠肺炎时代，与环磷酰胺或普乐沙福联合应用时，来那度胺诱导时间延长并不会显著影响多发性骨髓瘤患者干细胞采集。
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e716-e729. doi: 10.1016/j.clml.2022.03.013. Epub 2022 Mar 28.
10
Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.新诊断多发性骨髓瘤患者自体干细胞移植（ASCT）前诱导治疗：更新。
Blood Cancer J. 2022 Mar 28;12(3):47. doi: 10.1038/s41408-022-00645-1.